Biotech startup Oxford Nanopore picks London for IPO
April 1, 2021
DNA sequencing startup Oxford Nanopore Technologies is planning to list on the London Stock Exchange in the second half of the year. The UK-based company is expected to be valued at between £4 billion and £7 billion, the Financial Times reported. Oxford Nanopore has received more than £600 million in funding to date.